(EL) Estee Lauder Companies - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US5184391044
Stock: Skin Care, Makeup, Fragrance, Hair Care
Total Rating 54
Risk 87
Buy Signal -0.80
| Risk 5d forecast | |
|---|---|
| Volatility | 49.1% |
| Relative Tail Risk | -15.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.97 |
| Alpha | 21.05 |
| Character TTM | |
|---|---|
| Beta | 1.262 |
| Beta Downside | 1.077 |
| Drawdowns 3y | |
|---|---|
| Max DD | 79.85% |
| CAGR/Max DD | -0.32 |
EPS (Earnings per Share)
Revenue
Description: EL Estee Lauder Companies March 05, 2026
Estée Lauder Companies Inc. (EL) manufactures and sells a global portfolio of skincare, makeup, fragrance, and hair care products. This includes a wide range of offerings from moisturizers and cleansers to foundations, lipsticks, and various fragrance forms. The beauty industry is characterized by strong brand loyalty and frequent product innovation.
The company distributes its products through diverse channels, including department stores, duty-free retailers, specialty stores, and online platforms. Its brand portfolio features numerous well-known names like La Mer, Jo Malone London, Estée Lauder, Clinique, and M·A·C. The direct-to-consumer business model, encompassing freestanding stores and brand websites, is a growing trend in consumer goods.
To gain further insights into ELs performance and market position, consider exploring its detailed financials on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income: -178.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -0.00 > 1.0 |
| NWC/Revenue: 12.86% < 20% (prev 12.29%; Δ 0.57% < -1%) |
| CFO/TA 0.09 > 3% & CFO 1.67b > Net Income -178.0m |
| Net Debt (7.96b) to EBITDA (1.59b): 5.02 < 3 |
| Current Ratio: 1.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (364.8m) vs 12m ago 1.33% < -2% |
| Gross Margin: 74.35% > 18% (prev 0.73%; Δ 7362 % > 0.5%) |
| Asset Turnover: 74.51% > 50% (prev 76.80%; Δ -2.29% > 0%) |
| Interest Coverage Ratio: 1.96 > 6 (EBITDA TTM 1.59b / Interest Expense TTM 390.0m) |
Altman Z'' 3.53
| A: 0.10 (Total Current Assets 7.16b - Total Current Liabilities 5.27b) / Total Assets 19.63b |
| B: 0.59 (Retained Earnings 11.62b / Total Assets 19.63b) |
| C: 0.04 (EBIT TTM 766.0m / Avg Total Assets 19.70b) |
| D: 0.68 (Book Value of Equity 10.55b / Total Liabilities 15.60b) |
| Altman-Z'' Score: 3.53 = A |
Beneish M -3.16
| DSRI: 1.06 (Receivables 1.66b/1.61b, Revenue 14.68b/15.18b) |
| GMI: 0.98 (GM 74.35% / 73.08%) |
| AQI: 0.92 (AQ_t 0.37 / AQ_t-1 0.40) |
| SGI: 0.97 (Revenue 14.68b / 15.18b) |
| TATA: -0.09 (NI -178.0m - CFO 1.67b) / TA 19.63b) |
| Beneish M-Score: -3.16 (Cap -4..+1) = AA |
What is the price of EL shares?
As of March 05, 2026, the stock is trading at USD 99.21 with a total of 3,580,228 shares traded.
Over the past week, the price has changed by -11.87%, over one month by -16.80%, over three months by -4.14% and over the past year by +48.03%.
Over the past week, the price has changed by -11.87%, over one month by -16.80%, over three months by -4.14% and over the past year by +48.03%.
Is EL a buy, sell or hold?
Estee Lauder Companies has received a consensus analysts rating of 3.11.
Therefor, it is recommend to hold EL.
- StrongBuy: 2
- Buy: 1
- Hold: 23
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the EL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 107.8 | 8.7% |
| Analysts Target Price | 107.8 | 8.7% |
EL Fundamental Data Overview March 05, 2026
P/E Forward = 33.557
P/S = 2.4338
P/B = 8.9907
P/EG = 2.0684
Revenue TTM = 14.68b USD
EBIT TTM = 766.0m USD
EBITDA TTM = 1.59b USD
Long Term Debt = 7.32b USD (from longTermDebt, last quarter)
Short Term Debt = 416.0m USD (from shortTermDebt, last quarter)
Debt = 11.04b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.96b USD (from netDebt column, last quarter)
Enterprise Value = 43.67b USD (35.71b + Debt 11.04b - CCE 3.08b)
Interest Coverage Ratio = 1.96 (Ebit TTM 766.0m / Interest Expense TTM 390.0m)
EV/FCF = 38.41x (Enterprise Value 43.67b / FCF TTM 1.14b)
FCF Yield = 2.60% (FCF TTM 1.14b / Enterprise Value 43.67b)
FCF Margin = 7.75% (FCF TTM 1.14b / Revenue TTM 14.68b)
Net Margin = -1.21% (Net Income TTM -178.0m / Revenue TTM 14.68b)
Gross Margin = 74.35% ((Revenue TTM 14.68b - Cost of Revenue TTM 3.77b) / Revenue TTM)
Gross Margin QoQ = 76.55% (prev 73.37%)
Tobins Q-Ratio = 2.22 (Enterprise Value 43.67b / Total Assets 19.63b)
Interest Expense / Debt = 0.74% (Interest Expense 82.0m / Debt 11.04b)
Taxrate = 45.35% (151.0m / 333.0m)
NOPAT = 418.7m (EBIT 766.0m * (1 - 45.35%))
Current Ratio = 1.36 (Total Current Assets 7.16b / Total Current Liabilities 5.27b)
Debt / Equity = 2.74 (Debt 11.04b / totalStockholderEquity, last quarter 4.03b)
Debt / EBITDA = 5.02 (Net Debt 7.96b / EBITDA 1.59b)
Debt / FCF = 7.00 (Net Debt 7.96b / FCF TTM 1.14b)
Total Stockholder Equity = 4.03b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.90% (Net Income -178.0m / Total Assets 19.63b)
RoE = -4.41% (Net Income TTM -178.0m / Total Stockholder Equity 4.03b)
RoCE = 6.75% (EBIT 766.0m / Capital Employed (Equity 4.03b + L.T.Debt 7.32b))
RoIC = 3.69% (NOPAT 418.7m / Invested Capital 11.35b)
WACC = 8.16% (E(35.71b)/V(46.75b) * Re(10.56%) + D(11.04b)/V(46.75b) * Rd(0.74%) * (1-Tc(0.45)))
Discount Rate = 10.56% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.66%
[DCF] Terminal Value 69.49% ; FCFF base≈1.14b ; Y1≈748.5m ; Y5≈341.5m
[DCF] Fair Price = N/A (negative equity: EV 6.49b - Net Debt 7.96b = -1.47b; debt exceeds intrinsic value)
EPS Correlation: -28.19 | EPS CAGR: -18.31% | SUE: 0.34 | # QB: 0
Revenue Correlation: -29.37 | Revenue CAGR: -0.04% | SUE: 0.00 | # QB: 0
EPS current Year (2026-06-30): EPS=2.22 | Chg7d=+0.019 | Chg30d=+0.054 | Revisions Net=+15 | Growth EPS=+47.1% | Growth Revenue=+4.7%
EPS next Year (2027-06-30): EPS=3.03 | Chg7d=+0.019 | Chg30d=+0.094 | Revisions Net=+14 | Growth EPS=+36.5% | Growth Revenue=+4.3%
[Analyst] Revisions Ratio: +0.65 (19 Up / 4 Down within 30d for Current Year)
P/S = 2.4338
P/B = 8.9907
P/EG = 2.0684
Revenue TTM = 14.68b USD
EBIT TTM = 766.0m USD
EBITDA TTM = 1.59b USD
Long Term Debt = 7.32b USD (from longTermDebt, last quarter)
Short Term Debt = 416.0m USD (from shortTermDebt, last quarter)
Debt = 11.04b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.96b USD (from netDebt column, last quarter)
Enterprise Value = 43.67b USD (35.71b + Debt 11.04b - CCE 3.08b)
Interest Coverage Ratio = 1.96 (Ebit TTM 766.0m / Interest Expense TTM 390.0m)
EV/FCF = 38.41x (Enterprise Value 43.67b / FCF TTM 1.14b)
FCF Yield = 2.60% (FCF TTM 1.14b / Enterprise Value 43.67b)
FCF Margin = 7.75% (FCF TTM 1.14b / Revenue TTM 14.68b)
Net Margin = -1.21% (Net Income TTM -178.0m / Revenue TTM 14.68b)
Gross Margin = 74.35% ((Revenue TTM 14.68b - Cost of Revenue TTM 3.77b) / Revenue TTM)
Gross Margin QoQ = 76.55% (prev 73.37%)
Tobins Q-Ratio = 2.22 (Enterprise Value 43.67b / Total Assets 19.63b)
Interest Expense / Debt = 0.74% (Interest Expense 82.0m / Debt 11.04b)
Taxrate = 45.35% (151.0m / 333.0m)
NOPAT = 418.7m (EBIT 766.0m * (1 - 45.35%))
Current Ratio = 1.36 (Total Current Assets 7.16b / Total Current Liabilities 5.27b)
Debt / Equity = 2.74 (Debt 11.04b / totalStockholderEquity, last quarter 4.03b)
Debt / EBITDA = 5.02 (Net Debt 7.96b / EBITDA 1.59b)
Debt / FCF = 7.00 (Net Debt 7.96b / FCF TTM 1.14b)
Total Stockholder Equity = 4.03b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.90% (Net Income -178.0m / Total Assets 19.63b)
RoE = -4.41% (Net Income TTM -178.0m / Total Stockholder Equity 4.03b)
RoCE = 6.75% (EBIT 766.0m / Capital Employed (Equity 4.03b + L.T.Debt 7.32b))
RoIC = 3.69% (NOPAT 418.7m / Invested Capital 11.35b)
WACC = 8.16% (E(35.71b)/V(46.75b) * Re(10.56%) + D(11.04b)/V(46.75b) * Rd(0.74%) * (1-Tc(0.45)))
Discount Rate = 10.56% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.66%
[DCF] Terminal Value 69.49% ; FCFF base≈1.14b ; Y1≈748.5m ; Y5≈341.5m
[DCF] Fair Price = N/A (negative equity: EV 6.49b - Net Debt 7.96b = -1.47b; debt exceeds intrinsic value)
EPS Correlation: -28.19 | EPS CAGR: -18.31% | SUE: 0.34 | # QB: 0
Revenue Correlation: -29.37 | Revenue CAGR: -0.04% | SUE: 0.00 | # QB: 0
EPS current Year (2026-06-30): EPS=2.22 | Chg7d=+0.019 | Chg30d=+0.054 | Revisions Net=+15 | Growth EPS=+47.1% | Growth Revenue=+4.7%
EPS next Year (2027-06-30): EPS=3.03 | Chg7d=+0.019 | Chg30d=+0.094 | Revisions Net=+14 | Growth EPS=+36.5% | Growth Revenue=+4.3%
[Analyst] Revisions Ratio: +0.65 (19 Up / 4 Down within 30d for Current Year)